Use of Cuban Granulated ÃÂ-Tricalcium Phosphate Ã¢ÂÂ Biograft-G Ã¢ÂÂ as Maxilar Bone Graft
Pérez Alvarez MC1,2*, Delgado García-Menocal JA2, Almirall La Serna2, Alfonso HA2, Collins J3, Fernández Díaz MI1, Márquez AD1, Rodríguez Hernandez JA1, Rodríguez CO4, Somonte Dávila H5, Guerra Bretaña RM2 and Morejón AL2
- *Corresponding Author:
- Mayra de la Caridad Pérez Álvarez
Center for Biomaterials
University of Havana
Ave Universidad, Havana Cuba
Tel: +53 47 374197; +53 5237-1238
E-mail: [email protected]
Received Date: April 30, 2013; Accepted Date: May 25, 2013; Published Date: May 28, 2013
Citation: Pérez Alvarez MC, Delgado García-Menocal JA, Almirall La Serna, Alfonso HA, Collins J, et al. (2013) Use of Cuban Granulated B-Tricalcium Phosphate “Biograft-G” as Maxilar Bone Graft. J Oral Hyg Health 1:103. doi: 10.4172/2332-0702.1000103
Copyright: © 2013 Pérez Alvarez MC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In maxillary bone, several pathologies or lesions may cause maxillary alveolar atrophic (MAA), that is, a bone reabsorption frequently provoked by tooth loses or extractions. Tooth loses or extractions are one of the most common clinical situations observed in patients. The MAA could become a signifi cant functional and aesthetic risk for the use of tooth implants or any other prosthetic rehabilitation. Several biomaterials have been used as bone graft; they must fulfi l requirements like biocompatibility and a suitable function. A synthetic dense ceramic granulate of β-TCP, BIOGRAFT-G® (BIOMAT), in form of irregular shape granules with a grain size between 0.1 mm and 0.4 mm, was used in this study as graft material. The clinical studies include 178 patients, treated in Pre-implantology and Trans-implantology bone remodelling, prevention of residual ridge reabsorption by socket grafting and Periapical Surgical. In the fi nal evaluation of effectiveness after 6 month of surgery most of cases were qualifi ed as Success (98.3%), observing in the treated site a remodeled bone similar to the one in the adjacent tissue and almost no trace of implanted biomaterial. However, 3 cases were qualifi ed as Failure, all of them in patients that underwent the fi lling of dental sockets treatment, caused by the exfoliation of granules or a septic process. According to the obtained results, Biograft-G® proved to be a biodegradable, biocompatible, effectiveness and safety bone graft biomaterial in the studied treatments.